期刊文献+

Ifenprodil对肌萎缩侧索硬化离体模型中运动神经元的保护作用 被引量:1

Protective effect of Ifenprodil on motor neurons in in vitro amyotrophic lateral sclerosis models
原文传递
导出
摘要 目的探讨Ifenprodil对苏-羟天冬氨酸(THA)诱导的肌萎缩侧索硬化(ALS)离体模型中运动神经元的保护作用。方法在离体培养的脑组织片中加入THA造成慢性谷氨酸损伤,模拟肌萎缩侧索硬化的特征性病理改变。将脑片分为6组:(1)对照组,不添加THA;(2)THA损伤组,细胞换液时加入100μmol/LTHA,持续1周;(3)不同剂量Ifenprodilgfl(分别在THA损伤基础上添加0.1、l、10、100μmol/LIfenprodil);每组6个培养皿。Ifenprodil于THA损伤前2h加入到各组脑片中。根据PI染色的荧光亮度测定Ifenprodil保护作用的最佳浓度。在损伤的不同时间点用丙二醛fMDA)试剂盒测定培养体系中MDA的含量,Westem blotting测定运动皮层中半胱氨酸天冬氨酸酶-3(caspase-3)蛋白表达量。结果PI染色显示10μmol/LIfenprodil对运动神经元有明显保护作用。THA损伤后,培养体系中MDA含量明显增加,运动皮层中caspase-3活化亚基f相对分子量为17000)表达量增高,与其他组别比较差异有统计学意义(P〈0.05)。10ixmol/LIfenprodil能有效阻止MDA和活化caspase-3的增加。结论Ifenprodil能够通过减轻运动神经元的氧化应激反应.抑制caspase-3活化,进而有效保护ALS离体模型中运动神经元的损伤。 Objective To investigate the protective effect of Ifenprodil on motor neurons in invitro threo-hydroxyaspartate (THA)-induced amyotrophic lateral sclerosis (ALS) models. Methods THA was added into the isolated culture of brain slices to induce chronic glutamate damage and mimic the typical changes of ALS pathology. Cultured brain slices were separated randomly to 6 different groups, including control group (without THA), THA inducement group (adding 100μmol/L THA for one week) and THA and Ifenprodil treatment groups (adding 0.1, 1, 10 and 100 μmol/L of Ifenprodil 2 h before 100 μmol/L THA inducement); 6 culture dishes were employed in each group. According to PI fluorescence intensity, the most effective concentration oflfenprodil was selected. The concentration of malonaldehyde (MDA) in supernatant of cultured tissues was evaluated by MDA testing kit and the protein expression of cysteine-aspartic proteases-3 (caspase-3) in motor cortex was tested by Western blotting at different injury times. Results PI staining showed that 10μmol/L Ifenprodil could produce prominent protective effect on motor neurons in the ALS models. Levels of MDA in supernatant and activated 17KD caspase-3 in the THA treatment group obviously increased as compared with those in the other groups (P〈0.05); 10 μmol/L Ifenprodil could block the increment of MDA and activated caspase-3 levels effectively. Conclusion Ifenprodil can effectively protect motor neurons in in vitro THA-induced ALS models by reducing oxidative stress and inhibiting casloase-3 activation.
作者 郑梅 樊东升
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2012年第12期1192-1196,共5页 Chinese Journal of Neuromedicine
基金 国家自然科学基金(81200969,81030019) 北京大学第三医院回国人员启动基金(73526-01)
关键词 运动神经元 肌萎缩侧索硬化 IFENPRODIL Motor neuron Amyotrophic lateral sclerosis Ifenprodil
  • 相关文献

参考文献16

  • 1D'Alessandro G, Calcagno E, Tartari S, et al. Glutamate and glutathione interplay in a motor neuronal model of amyotrophic lateral sclerosis reveals altered energy metabolism [J]. Neurobiol Dis, 2011, 43(2): 346-355.
  • 2Van Den Bosch L, Van Damme P, Bogaert E, et al. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis [J]. Biochim Biophys Acta, 2006, 1762(11-12): 1068-1082.
  • 3Wood PL. The NMDA receptor complex: a long and winding road to therapeutics [J]. IDrugs, 2005, 8(3): 229-235.
  • 4Liu Y, Wong TP, Aarts M, et al. NMDA receptor subtmits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo [J]. J Neurosci, 2007, 27(11): 2846-2857.
  • 5Chen M, Lu T J, Chen X J, et al. Differential roles of NMDA receptor subtypes in ischemic neuronal cell death and ischemic tolerance [J]. Stroke, 2008, 39(11): 3042-3048.
  • 6Mishra V, Verma R, Singh N, et al. The neuroprotective effects of NMDAR antagonist, ifenprodil and ASICla inhibitor, flurbiprofen on post-ischemic cerebral injury [J]. Brain Res, 2011, 1389 (10): 152-160.
  • 7Nash JE, Brotchie JM. Characterisation of striatal NMDA receptors involved in the generation ofparkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat [J]. Mov Disord, 2002, 17(3): 455-466.
  • 8Smith JP, Lal V, Bowser D, et al. Stimulus pattern dependence of the Alzheimer's disease amyloid-beta 42 peptide's inhibition of long term potentiation in mouse hippocampal slices [J]. Brain Res, 2009, 1269(7): 76-84.
  • 9Rothstein JD, Jin L, Dykes-Hoberg M, et al. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity [J]. Proc Natl Acad Sci U S A, 1993, 90(14): 6591-6595.
  • 10Barber SC, Shaw PJ. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target [J]. Free Radio Biol Med, 2010, 48(5): 629-641.

同被引文献18

  • 1Naganska E,Matyja E. Amyotrophic lateral sclerosis-looking for pathogenesis and effective therapy[J].Folia neuropathologica,2011,(01):1-13.
  • 2Cantley LC. The phosphoinositide 3-kinase pathway[J].Science,2002,(5573):1655-1657.
  • 3Ragonese P,Cellura E,Aridon P. Incidence of amyotrophic lateral sclerosis in Sicily:A population based study[J].Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders,2012,(03):284-287.
  • 4Hardiman O,van den Berg LH,Kieman MC. Clinical diagnosis and management ofamyotrophic lateral scleosis[J].Nature Reviews Neurology,2011,(11):639-649.
  • 5Kiernan MC,Vucic S,Cheah BC. Amyotroph Lateral sclerosis[J].The Lancet,2011,(9769):942-955.
  • 6Pradat PF,Barani A,Wanschitz J. Abnormalities of satellite cells function in amyotrophic lateral sclerosis[J].Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders,2011,(04):264-271.
  • 7Dupuis L,di Scala F,Rene F. Up-regulation of mitochondrial uncoupling protein 3 reveals an early muscular metabolic defect in amyotrophic lateral sclerosis[J].Federation of American Societies for Experimental Biology,2003,(14):2091-2093.
  • 8Ghiasi P,Hosseinkhani S,Noori A. Mitochondrial complex I deficiency and ATP/ADP ratio in lymphocytes of amyotrophiclateral sclerosis patients[J].Neurological Research,2012,(03):297-303.
  • 9Muller FL,Song W,Jang YC. Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production[J].American Journal of Physiology-Regulatory Integrative and Comparative Physiology,2007,(03):1159-1168.
  • 10Reiff DM,Spathis R,Chan CW. Inherited and somatic mitochondrial DNA mutations in Guam amyotrophic lateral sclerosis and parkinsonism-dementia[J].Neurological Sciences,2011,(05):883-892.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部